Therefore, the role of CTSB in glioma-related immune response and immunosuppression makes it possible to use CTSB as a therapeutic target enhancing the host immune system to interfere with immune evasion of glioma cells, which is a promising prerequisite in improving the reactivity of targeted therapy for gliomas62. The gene discussed is CTSB; the disease is glioma.